Showing 1 - 6 results of 6 for search 'Philipp Oster', query time: 0.03s Refine Results
  1. 1
    Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age

    Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age by Gary S. Marshall, Stephen I. Pelton, Corwin A. Robertson, Philipp Oster

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Immune persistence and booster response of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) 5 years after primary vaccination of adults at ≥56 years of age

    Immune persistence and booster response of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) 5 years after primary vaccination of adults at ≥56 years of age by Corwin A. Robertson, Jeffry Jacqmein, Alexandre Selmani, Katherine Galarza, Philipp Oster

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature

    Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature by Sandra Guedes, Isabelle Bertrand-Gerentes, Keith Evans, Florence Coste, Philipp Oster

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study

    Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study by Corwin A. Robertson, Jeffry Jacqmein, Alexandre Selmani, Katherine Galarza, Philipp Oster

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Safety and immunogenicity of meningococcal (Groups A and C) polysaccharide vaccine in children 2 to 6 y of age in China: a randomized, active-controlled, non-inferiority study

    Safety and immunogenicity of meningococcal (Groups A and C) polysaccharide vaccine in children 2 to 6 y of age in China: a randomized, active-controlled, non-inferiority study by Feng-Cai Zhu, Yue-Mei Hu, Ya-Nan Li, Jean-Denis Shu, Philipp Oster

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial

    Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C... by Markus Knuf, Mika Rämet, Nina Breinholt Stærke, Isabelle Bertrand-Gerentes, Yaël Thollot, Siham B'Chir, Habiba Arroum, Philipp Oster

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: